Search Results

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy.

• Authors : Cooper DA; Cordery DV ...

Subjects: Body Composition/Body Composition/Body Composition/*drug effects ; Dyslipidemias/Dyslipidemias/Dyslipidemias/*chemically induced ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*adverse effects

• Source: HIV medicine [HIV Med] 2011 Jan; Vol. 12 (1), pp. 31-9.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Internet ISSN: 1468-1293 (Electronic)

Record details

A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration.

• Authors : Loutfy MR; Department of Medicine, University of Toronto, Maple Leaf Medical Clinic, and Department of Family and Community Medicine, St Michael's Hospital, Toronto, Ontario, Canada. ; Harris M

Subjects: HIV*; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*administration & dosage ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*administration & dosage

• Source: HIV medicine [HIV Med] 2007 Oct; Vol. 8 (7), pp. 427-32.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN: 1464-2662 (Print)

Record details

Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.

• Authors : Macías J; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/*administration & dosage ; Cyclohexanes/Cyclohexanes/Cyclohexanes/*administration & dosage

• Source: HIV medicine [HIV Med] 2014 Aug; Vol. 15 (7), pp. 417-24. Date of Electronic Publication: 2014 Feb 24.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

• Authors : Carsenti-Dellamonica H; Infectiology Unit, University Nice Sophia-Antipolis, Nice, France.; Saïdi H

Subjects: CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/*immunology ; Chemokine CXCL10/Chemokine CXCL10/Chemokine CXCL10/*blood ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use

• Source: HIV medicine [HIV Med] 2011 Feb; Vol. 12 (2), pp. 65-77.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Internet ISSN: 1468-1293 (Electronic)

Record details

Poster Abstracts.

Subjects: ANTIRETROVIRAL agents; CONFERENCES & conventions; HIV infectionsUNITED Kingdom

• Source: HIV Medicine. Apr2016 Supplement, Vol. 17, p14-71. 58p.

Record details

Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.

• Authors : Iniesta-Navalón C; Department of Hospital Pharmacy, Queen Sofia Hospital of Murcia, Spain.; Franco-Miguel JJ

Subjects: Drug Interactions*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: HIV medicine [HIV Med] 2015 May; Vol. 16 (5), pp. 273-9. Date of Electronic Publication: 2014 Dec 18.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

New drugs.

• Authors : Waters L; Department of HIV Medicine, St Stephen's Centre, Chelsea and Westminster Hospital, London, UK.; Nelson MR

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use; Benzophenones/Benzophenones/Benzophenones/therapeutic use ; Cytidine Triphosphate/Cytidine Triphosphate/Cytidine Triphosphate/analogs & derivatives

• Source: HIV medicine [HIV Med] 2005 Jul; Vol. 6 (4), pp. 225-31.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print Cited Medium: Print ISSN: 1464-2662 (Print)

Record details